English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:  Zhou, Guangyu;  Fu, Shengyu;  Zhang, Yunsen;  Li, Shuang;  Guo, Ziang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date：2024/08/05
Car-t Cell  Her2  Monoclonal Antibody  Trastuzumab  
Uncertainty-aware Hierarchical Aggregation Network for Medical Image Segmentation Journal article
Zhou, Tao, Zhou, Yi, Li, Guangyu, Chen, Geng, Shen, Jianbing. Uncertainty-aware Hierarchical Aggregation Network for Medical Image Segmentation[J]. IEEE Transactions on Circuits and Systems for Video Technology, 2024, 34(8), 7440 - 7453.
Authors:  Zhou, Tao;  Zhou, Yi;  Li, Guangyu;  Chen, Geng;  Shen, Jianbing
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:8.3/7.1 | Submit date：2024/05/16
Biomedical Imaging  Feature Extraction  Fuses  Hierarchical Feature Fusion  Image Segmentation  Lesions  Medical Diagnostic Imaging  Medical Image Segmentation  Scale Aggregation Module  Semantics  Uncertainty-induced Cross-level Fusion  
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment Journal article
Huang Shigao, Xing Fuqiang, Dai Yeneng, Zhang Zhiming, Zhou Guangyu, Yang Shuo, Liu Yu-Cheng, Yuan Zhen, Luo Kathy Qian, Ying Tianlei, Chu Dafeng, Liu Tzu-Ming, Deng Chu-Xia, Zhao Qi. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment[J]. Journal of Controlled Release, 2023, 362, 524-535.
Authors:  Huang Shigao;  Xing Fuqiang;  Dai Yeneng;  Zhang Zhiming;  Zhou Guangyu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:10.5/10.6 | Submit date：2023/09/28
Car-nk Cells  Tumor Microenvironment  Three-dimensional Slice Culture  Photothermal Therapy  Intravital Two-photon Imaging  
NTIRE 2022 Challenge on High Dynamic Range Imaging: Methods and Results Conference paper
Perez-Pellitero, Eduardo, Catley-Chandar, Sibi, Shaw, Richard, Leonardis, Ales, Timofte, Radu, Zhang, Zexin, Liu, Cen, Peng, Yunbo, Lin, Yue, Yu, Gaocheng, Zhang, Jin, Ma, Zhe, Wang, Hongbin, Chen, Xiangyu, Wang, Xintao, Wu, Haiwei, Liu, Lin, Dong, Chao, Zhou, Jiantao, Yan, Qingsen, Zhang, Song, Chen, Weiye, Liu, Yuhang, Zhang, Zhen, Zhang, Yanning, Shi, Javen Qinfeng, Gong, Dong, Zhu, Dan, Sun, Mengdi, Chen, Guannan, Hu, Yang, Li, Haowei, Zou, Baozhu, Liu, Zhen, Lin, Wenjie, Jiang, Ting, Jiang, Chengzhi, Li, Xinpeng, Han, Mingyan, Fan, Haoqiang, Sun, Jian, Liu, Shuaicheng, Marin-Vega, Juan, Sloth, Michael, Schneider-Kamp, Peter, Rottger, Richard, Li, Chunyang, Bao, Long, He, Gang, Xu, Ziyao, Xu, Li, Zhan, Gen, Sun, Ming, Wen, Xing, Li, Junlin, Li, Jinjing, Li, Chenghua, Gang, Ruipeng, Li, Fangya, Liu, Chenming, Feng, Shuang, Lei, Fei, Liu, Rui, Ruan, Junxiang, Dai, Tianhong, Li, Wei, Lu, Zhan, Liu, Hengyan, Huang, Peian, Ren, Guangyu, Luo, Yonglin, Liu, Chang, Tu, Qiang, Ma, Sai, Cao, Yizhen, Tel, Steven, Heyrman, Barthelemy, Ginhac, Dominique, Lee, Chul, Kim, Gahyeon, Park, Seonghyun, An Gia Vien, Truong Thanh Nhat Mai, Yoon, Howoon, Tu Vo, Holston, Alexander, Zaheer, Sheir, Park, Chan Y.. NTIRE 2022 Challenge on High Dynamic Range Imaging: Methods and Results[C], 2022, 1008-1022.
Authors:  Perez-Pellitero, Eduardo;  Catley-Chandar, Sibi;  Shaw, Richard;  Leonardis, Ales;  Timofte, Radu; et al.
Favorite | TC[WOS]:11 TC[Scopus]:28 | Submit date：2023/01/30
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes Journal article
Liu, Jie, Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhang, Fengjuan, Wang, Yuan, Wang, Rixin, Zhu, Lipeng, Meng, Ya, Hu, Cong, Liang, Hui, Lin, Xu, Zhu, Kangshun, Chen, Guokai, Luo, Kathy Qian, Di, Lijun, Zhao, Qi. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes[J]. Journal of Hematology and Oncology, 2021, 14(1), 1-18.
Authors:  Liu, Jie;  Yang, Shuo;  Cao, Bihui;  Zhou, Guangyu;  Zhang, Fengjuan; et al.
Favorite | TC[WOS]:60 TC[Scopus]:64  IF:29.5/26.9 | Submit date：2021/03/04
B7-h3  Bike  Bispecific Antibody  Car t  Chimeric Antigen Receptor  Non-small Cell Lung Cancer  Pd-l1  
Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy Journal article
Zhu, Lipeng, Liu, Jie, Zhou, Guangyu, Liu, Tzu Ming, Dai, Yunlu, Nie, Guangjun, Zhao, Qi. Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy[J]. Small, 2021, 17(43), 2102624.
Authors:  Zhu, Lipeng;  Liu, Jie;  Zhou, Guangyu;  Liu, Tzu Ming;  Dai, Yunlu; et al.
Adobe PDF | Favorite | TC[WOS]:59 TC[Scopus]:62  IF:13.0/13.5 | Submit date：2021/12/08
B7-h3 Immune Checkpoint  Chimeric Antigen Receptor t Cell  Immunotherapy  Nanozyme  Photothermal-nanocatalytic Effect  
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer Journal article
Yang,Shuo, Cao,Bihui, Zhou,Guangyu, Zhu,Lipeng, Wang,Lu, Zhang,Li, Kwok,Hang Fai, Zhang,Zhenfeng, Zhao,Qi. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer[J]. Frontiers in Pharmacology, 2020, 11, 1089.
Authors:  Yang,Shuo;  Cao,Bihui;  Zhou,Guangyu;  Zhu,Lipeng;  Wang,Lu; et al.
Favorite | TC[WOS]:45 TC[Scopus]:48  IF:4.4/5.0 | Submit date：2021/03/04
B7-h3  Chimeric Antigen Receptor  Immune Checkpoint  Natural Killer Cell  Nk-92  
Perspectives on therapeutic neutralizing antibodies against the novel coronavirus sars-cov-2 Journal article
Zhou Guangyu, Zhao Qi. Perspectives on therapeutic neutralizing antibodies against the novel coronavirus sars-cov-2[J]. International Journal of Biological Sciences, 2020, 16(10), 1718-1723.
Authors:  Zhou Guangyu;  Zhao Qi
Favorite | TC[WOS]:180 TC[Scopus]:208  IF:8.2/8.3 | Submit date：2021/03/04
Covid-19  Neutralizing Antibody  Sars-cov-2  Severe Acute Respiratory Syndrome  
Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing Journal article
Jie Liu, Guangyu Zhou, Li Zhang, Qi Zhao. Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing[J]. FRONTIERS IN IMMUNOLOGY, 2019, 10.
Authors:  Jie Liu;  Guangyu Zhou;  Li Zhang;  Qi Zhao
Favorite | TC[WOS]:60 TC[Scopus]:61  IF:5.7/6.8 | Submit date：2020/05/14
Chimeric Antigen Receptor  Crispr  Gene Editing  Immunotherapy  Cancer  Car t  
Targeting immune checkpoint B7-H3 antibody-chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy Journal article
Zhu,Lipeng, Liu,Jie, Zhou,Guangyu, Ng,Hoi Man, Ang,Irene L., Ma,Guofang, Liu,Yubin, Yang,Shuo, Zhang,Fengjuan, Miao,Kai, Poon,Terence C.W., Zhang,Xuanjun, Yuan,Zhen, Deng,Chu Xia, Zhao,Qi. Targeting immune checkpoint B7-H3 antibody-chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy[J]. Chemical Communications, 2019, 55(95), 14255-14258.
Authors:  Zhu,Lipeng;  Liu,Jie;  Zhou,Guangyu;  Ng,Hoi Man;  Ang,Irene L.; et al.
Favorite | TC[WOS]:24 TC[Scopus]:25  IF:4.3/4.4 | Submit date：2020/09/16